GPR156
Probable G-protein coupled receptor 156
Also known as: GABABL, GP156_HUMAN, PGR28
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NFN8
- Gene
- GPR156
- Ensembl
- ENSG00000175697
- Chromosome
- 3
- Canonical length
- 814 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
G protein-coupled receptors (GPCRs) are a large superfamily of cell surface receptors characterized by 7 helical transmembrane domains, together with N-terminal extracellular and C-terminal intracellular domains.[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
814 residues, UniProt reviewed canonical sequence.
>Q8NFN8|GPR156
1 MEPEINCSEL CDSFPGQELD RRPLHDLCKT TITSSHHSSK TISSLSPVLL GIVWTFLSCG
61 LLLILFFLAF TIHCRKNRIV KMSSPNLNIV TLLGSCLTYS SAYLFGIQDV LVGSSMETLI
121 QTRLSMLCIG TSLVFGPILG KSWRLYKVFT QRVPDKRVII KDLQLLGLVA ALLMADVILL
181 MTWVLTDPIQ CLQILSVSMT VTGKDVSCTS TSTHFCASRY SDVWIALIWG CKGLLLLYGA
241 YLAGLTGHVS SPPVNQSLTI MVGVNLLVLA AGLLFVVTRY LHSWPNLVFG LTSGGIFVCT
301 TTINCFIFIP QLKQWKAFEE ENQTIRRMAK YFSTPNKSFH TQYGEEENCH PRGEKSSMER
361 LLTEKNAVIE SLQEQVNNAK EKIVRLMSAE CTYDLPEGAA PPASSPNKDV QAVASVHTLA
421 AAQGPSGHLS DFQNDPGMAA RDSQCTSGPS SYAQSLEGPG KDSSFSPGKE EKISDSKDFS
481 DHLDSGCSQK PWTEQSLGPE RGDQVPMNPS QSLLPERGGS DPQRQRHLEN SEEPPERRSR
541 VSSVIREKLQ EVLQDLGLGP EASLSTAPSC HQQTWKNSAA FSPQKMPLSK ELGFSPYMVR
601 RRRAAQRARS HFPGSAPSSV GHRANRTVPG AHSRLHVQNG DSPSLAPQTT DSRVRRPSSR
661 KPSLPSDPQD RPGTLEGSKQ SQTEPEGARG SKAAFLRQPS GSGRAPSPAA PCLSKASPDL
721 PEQWQLWPPV PSGCASLSSQ HSYFDTESSS SDEFFCRCHR PYCEICFQSS SDSSDSGTSD
781 TDPEPTGGLA SWEKLWARSK PIVNFKDDLK PTLVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPR156 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 2.5 nTPM
Expression across tissuesHPA
Tissue
- testis: 2.5 nTPM
- fallopian tube: 0.9 nTPM
- salivary gland: 0.6 nTPM
- urinary bladder: 0.5 nTPM
- ovary: 0.4 nTPM
- retina: 0.4 nTPM
Single-cell type
- late spermatids: 38 nCPM
- early primary spermatocytes: 35 nCPM
- müller glia: 34 nCPM
- ependymal cells: 32 nCPM
- retinal ganglion cells: 31 nCPM
- early spermatids: 30 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 1.1 nTPM
- amygdala: 1 nTPM
- spinal cord: 1 nTPM
- white matter: 1 nTPM
- basal ganglia: 0.9 nTPM
- medulla oblongata: 0.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GPR156.
Disease | AllUniProt
Conditions GPR156 is implicated in, by any mechanism.
- Deafness, autosomal recessive, 121 (DFNB121) MIM:620551
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 138 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hearing loss, autosomal recessive 121
- Hearing loss, autosomal recessive
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.04
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPR156 as an antibody target. Whether an autoantibody or antibody against GPR156 could matter depends on whether native GPR156 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPR156 is annotated at the cell surface, where native GPR156 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GPR156 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...